Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DiaKine and AdPharma to develop diabetes drugs
DiaKine said that the partnership would approach treating diabetes in a new way by preserving or restoring the patient's own insulin-producing cells. The first drug in the pipeline
DiaKine said that the partnership would approach treating diabetes in a new way by preserving or restoring the patient's own insulin-producing cells. The first drug in the pipeline
The Division of Bioequivalence has determined the Ranbaxy formulation to be bioequivalent and, therefore, therapeutically equivalent to Augmentin ES-600, which was developed by GlaxoSmithKline. Amoxicillin and clavulanate potassium
Ushercell is a cellulose sulfate-based topical microbicide gel. Polydex said that it was cellulose sulfate that could have lead to a potential increased risk of HIV infection in
Fentanyl Taifun is a fast-acting Fentanyl formulation delivered using its Taifun dry powder inhaler platform. Chronic pain associated with advanced cancer is commonly treated with strong opioid analgesics,
Net income dropped to $473.9 million, or 22 cents a share, from $1.12 billion, or 51 cents, a year earlier. Revenue in the quarter rose to $6.04 billion.
“The addition of this well respected Boston cancer center will enable enrollment of patients from the New England area who are suffering from this terrible late-stage cancer, and
Parsons looks to increase shareholder value with his business acumen, financing and acquisitions background beginning in the 1980s. These talents align perfectly to the vision XcelPlus has for
The company launched the product in the US following final approval from the FDA for Gedeon Richter's abbreviated new drug application. Barr's generic version of Proscar tablets, known
If Gestiva is approved, orphan drug designation provides the opportunity for seven years of US market exclusivity. A new drug application for Gestiva, a long-acting injectable form of
One of these, an osteoarthritis product, is currently approved and being marketed by Garvinci in Canada, while a second, an emergency contraceptive pill, has recently been approved and